Website maintenance is scheduled for March 4 from 11 p.m. to March 5 at 2 a.m. PT.
NTI

Concurrent A60M329

Revolution: A Deep Dive nto the Mechanism of Action and Clinical Impact of SGLT2 and GLP1 Agents

Facilitator(s): Lori Dugan Brien, DNP, ACNP-BC; Abbye Rae Solis, DNP, ACNP; Catherine Tierney, DNP, RN, ACNP-BC

Contact Hours 1.00
CERP A 1.00
Pharmacology Hours 1.00
San Diego Conference
Date Wednesday 5/20/2026
Time 7:30AM - 8:30AM PT
Virtual Conference
Date Monday 6/15/2026
Time 11:45AM - 1:15PM PT
Live Q & A

Session Summary

The benefits of SGLT2 inhibitors and GLP-1 receptor agonists, beyond their original purpose of glucose control, have some referring to these agents as wonder drugs. Evidence shows their benefit to patients with heart failure, chronic kidney disease, obesity and cardiovascular disease. APRNs must be aware of individuals who may benefit from being prescribed an SGLT2 inhibitor or a GLP-1 receptor agonist. This session describes the indications for and the pharmacology of SGLT2 inhibitors and GLP-1 receptor agonists. Case studies illustrate the benefits and risks associated with prescribing these medications. Pharmacology content = 100%

Objectives

  • Identify the mechanism of action, metabolism, dosing, side effects and cost of select SGLT2 inhibitors and GLP-1 receptor agonists.
  • Explain the cardiovascular, metabolic and renal benefits of SGLT2 inhibitors and GLP-1 receptor agonists.
  • Describe the risks associated with SGLT2 and GLP-1 inhibitor therapies.
Topics Pharmacology
Population Adult
Role APRN, Staff

Call for Abstracts: Have a great idea for a session or a poster?
Click here to apply.

Continuing Education Disclosure Statement

Successful Completion

Learners must complete the entire activity and the associated evaluation to be awarded contact hours AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

The American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for 1.00 contact hours.

Disclosure

Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Accreditation refers to recognition of continuing education only and does not imply AACN, ANCC, or CBRN approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity.

Activities with pharmacology hours are to assist the APRN in fulfilling the pharmacotherapeutic education requirements for licensure and certification renewals.

Activities meet the standards for most states that require mandatory continuing education for license and/or certification renewal. AACN recommends consulting with your own state board of nursing or credentialing organization before submitting your certificate of completion. 

Refund Policy

Continuing Education Activities are nonrefundable.